As one of the largest medical device companies in the world, Stryker (NYSE: SYK) will be a major beneficiary of this positive industry outlook. This means that investors should find thriving companies in growing industries, buy them, hold them, and occasionally monitor their fundamentals to make sure the investment thesis is intact. Elevated inflation and continued challenges to its supply chain were the catalysts that caused the company's non-GAAP net margin to drop 90 basis points over the year-ago period to 19.1% in the second quarter.